Present and future therapeutic strategies for idiopathic oligozoospermia

作者: Dimitrios A. Adamopoulos

DOI: 10.1046/J.1365-2605.2000.00258.X

关键词:

摘要: The effectiveness of medical treatment for idiopathic oligozoospermia (IO) has been at best doubtful until now and a logical consequence this unsatisfactory situation the partial displacement approach by assisted reproduction techniques. This state affairs resulted from insufficient investigation, inappropriately designed clinical trials consistent disregard principles evidence-based medicine. Protocol-related shortcomings wrong interpretation data available have also some all too frequent problems encountered in therapeutic approach. In rather misty situation, it appears that, agents used so far, follicle stimulating hormone (FSH) (mainly FSH-secretagogues) may exert beneficial effects on number biological endpoints related to spermatogenesis sperm maturation. short medium term prospects IO rest mainly with improvement investigative procedures higher degree sophistication, emphasis placed identifying causes than results dysfunction that better selection candidates can be made. Moreover, introduction prognostic indices evaluation agent paramount importance. Finally, assessment preparations and, possibly, new more specific an important step forward field. type large-scale effort should not left individual investigators or special centres working independently, but come under auspices central regulating agency undisputed large, multicentre uniform studies might obtained, if is remain good option. context, emphasized andrology's main task always treat male problem his healthy female partner, whenever possible.

参考文章(60)
D A Adamopoulos, Medical treatment of idiopathic oligozoospermia and male factor subfertility Asian Journal of Andrology. ,vol. 2, pp. 25- 32 ,(2000)
Allan R. Glass, Robert A. Vigersky, Leydig Cell Function in Idiopathic Oligospermia Fertility and Sterility. ,vol. 34, pp. 144- 148 ,(1980) , 10.1016/S0015-0282(16)44897-1
Youssef AinMelk, Serge Belisle, Michel Carmel, Tetreault Jean-Pierre, Tamoxifen citrate therapy in male infertility Fertility and Sterility. ,vol. 48, pp. 113- 117 ,(1987) , 10.1016/S0015-0282(16)59299-1
Ion-George Kotoulas, Emmanuel Cardamakis, John Michopoulos, Dionysis Mitropoulos, Athanasios Dounis, Tamoxifen treatment in male infertility. I. Effect on spermatozoa. Fertility and Sterility. ,vol. 61, pp. 911- 914 ,(1994) , 10.1016/S0015-0282(16)56705-3
B. Jégoua, The Sertoli-Germ Cell Communication Network in Mammals International Review of Cytology. ,vol. 147, pp. 25- 96 ,(1993) , 10.1016/S0074-7696(08)60766-4
K Sterzik, G Collodel, M Abt, E Strehler, P Piomboni, B Baccetti, U Bellati, R Wiedemann, M De Santo, The Effect of Follicle-Stimulating Hormone Therapy on Sperm Quality: An Ultrastructural Mathematical Evaluation Journal of Andrology. ,vol. 18, pp. 439- 447 ,(1997) , 10.1002/J.1939-4640.1997.TB01950.X
Patrick Vandekerckhove, Richard Lilford, Andy Vail, Edward Hughes, Androgens versus placebo or no treatment for idiopathic oligo/asthenospermia. Cochrane Database of Systematic Reviews. ,(1996) , 10.1002/14651858.CD000150
Carlo Foresta, Andrea Bettella, Alberto Ferlin, Andrea Garolla, Marco Rossato, Evidence for a Stimulatory Role of Follicle-Stimulating Hormone on the Spermatogonial Population in Adult Males Fertility and Sterility. ,vol. 69, pp. 636- 642 ,(1998) , 10.1016/S0015-0282(98)00008-9